Loading PROF charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading PROF comparable companies…
| PROFProfound Medical Corp.(opens in a new tab) | $0.24B | $0.02B | — | 72.7% | −187.6% | 12.62× | 14.2× |
|---|---|---|---|---|---|---|---|
| SRTSSensus Healthcare, Inc.(opens in a new tab) | $0.05B | $0.02B | −53.4% | 36.4% | −75.7% | 2.60× | — |
| NEPHNephros Inc.(opens in a new tab) | $0.04B | $0.02B | +24.2% | 61.3% | 7.9% | 1.74× | 20.3× |
| VVOSVivos Therapeutics, Inc.(opens in a new tab) | $0.00B | $0.02B | +45.2% | 61.9% | −107.9% | 0.10× | — |
| DRIODarioHealth Corp.(opens in a new tab) | $0.03B | $0.02B | −22.6% | 58.2% | −151.6% | 1.37× | 0.5× |
| Medianpeers, excl. PROF | $0.03B | $0.02B | +0.8% | 59.7% | −91.8% | 1.55× | 10.4× |